Home Cart Sign in  
Chemical Structure| 1628260-79-6 Chemical Structure| 1628260-79-6

Structure of Ziritaxestat
CAS No.: 1628260-79-6

Chemical Structure| 1628260-79-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

GLPG1690, a first-in-class autotaxin (ATX) inhibitor with IC50 of 131 nM and Ki of 15 nMl, is able to cause a sustained reduction of LPA levels in plasma in vivo and was shown to be efficacious in a bleomycin-induced pulmonary fibrosis model in mice, and in reducing extra-cellular matrix deposition in the lung whilst also reducing LPA 18:2 content in bronchoalveolar lavage fluid and may be a possible effectvie compound in treating idiopathic pulmonary fibrosis.

Synonyms: GLPG1690

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Ziritaxestat

CAS No. :1628260-79-6
Formula : C30H33FN8O2S
M.W : 588.70
SMILES Code : N#CC1=C(C2=CC=C(F)C=C2)N=C(N(C3=C(CC)N=C4C(C)=CC(N5CCN(CC(N6CC(O)C6)=O)CC5)=CN43)C)S1
Synonyms :
GLPG1690
MDL No. :MFCD31544330
InChI Key :REQQVBGILUTQNN-UHFFFAOYSA-N
Pubchem ID :90420193

Safety of Ziritaxestat

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT03976648 Systemic Sclerosis PHASE2 TERMINATED 2021-04-13 Pacific Arthritis Care Center,... More >> Los Angeles, California, 90045, United States|UCLA Rheumatology, Los Angeles, California, 90095, United States|RASF Clinical Research Center, Boca Raton, Florida, 33486, United States|University of Michigan, Ann Arbor, Michigan, 48109, United States|Metroplex Clinical Research Center, Dallas, Texas, 75231, United States|UT Physicians Center for Autoimmunity, Houston, Texas, 77030, United States|UZ Gent, Gent, 9000, Belgium|UZ Leuven, Leuven, 3000, Belgium|Azienda Ospedaliero Universitaria Careggi, Firenze, 50139, Italy|Ospedale San Raffaele S.r.l. - PPDS, Milano, 20132, Italy|Hospital Universitario Vall d'Hebron, Barcelona, 8035, Spain|Hospital Universitario 12 de Octubre, Madrid, 28041, Spain|University Hospital Aintree, Liverpool, L9 7AL, United Kingdom|Royal Free Hospital, London, NW32QG, United Kingdom Less <<
NCT03143712 Healthy PHASE1 COMPLETED 2017-06-14 SGS CPU, Antwerp, Belgium

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.70mL

0.34mL

0.17mL

8.49mL

1.70mL

0.85mL

16.99mL

3.40mL

1.70mL

References

 

Historical Records

Categories